ArticleBritish journal of pharmacology2004

Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.

Shu-Meng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.